2022
Electroencephalographic changes in purified pharmaceutical cannabidiol therapy
Herlopian A, Barnett JR, Nascimento FA, Lee H, Thiele EA. Electroencephalographic changes in purified pharmaceutical cannabidiol therapy. Epilepsy & Behavior 2022, 128: 108558. PMID: 35078115, DOI: 10.1016/j.yebeh.2022.108558.Peer-Reviewed Original ResearchConceptsInterictal epileptiform dischargesElectroencephalographic changesCBD treatmentIctal findingsSleep architectureEEG changesInvestigational New Drug programPredominant seizure typeNew drug programPre-treatment EEGYears of ageSubjective cognitive improvementElectrographic findingsElectrographic improvementRefractory epilepsySeizure typesClinical outcomesElectrographic changesEpileptiform dischargesPatientsCognitive improvementDrug programsSubstantial associationEEG studiesTreatment
2014
Crime and Psychiatric Disorders Among Youth in the US Population: An Analysis of the National Comorbidity Survey–Adolescent Supplement
Coker KL, Smith PH, Westphal A, Zonana HV, McKee SA. Crime and Psychiatric Disorders Among Youth in the US Population: An Analysis of the National Comorbidity Survey–Adolescent Supplement. Journal Of The American Academy Of Child & Adolescent Psychiatry 2014, 53: 888-898.e2. PMID: 25062596, PMCID: PMC4137504, DOI: 10.1016/j.jaac.2014.05.007.Peer-Reviewed Original ResearchConceptsNational Comorbidity Survey-Adolescent SupplementPsychiatric disordersPsychiatric comorbidityConduct disorderGreater oddsUS populationMental illnessDSM-IV-based diagnosisLifetime psychiatric disordersSpecific psychiatric disordersMental health servicesAlcohol use disorderRepresentative epidemiological sampleMore diagnosesUse disordersDrug useHealth servicesCommunity settingsLogistic regressionSimilar findingsDiagnosisEpidemiological sampleDisordersOddsSubstantial association
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply